Brasil Pharmaceuticals Private Limited - Company Profile

It is a paper private limited company based in Visakhapatnam, Andhra Pradesh, India, established in 2023.
2023 Visakhapatnam, Andhra Pradesh, India Active
Last Updated:
Access Report
About Brasil Pharmaceuticals Private Limited

Brasil Pharmaceuticals Private Limited, a active private limited company, was established on 28 February 2023 in Visakhapatnam, Andhra Pradesh, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21001AP2023PTC110452. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Veera Sathesh Gandhi Kamisetty (Director), Sravan Kumar Lakhineni (Director). Past directors included Renu Sarath Babu Vegesna, Ayyagari Srinivasa Rao. It is based at 49-35-49, 3Rd Floor, Sri Nivasam, Visakhapatnam, Andhra Pradesh, 530016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001AP2023PTC110452

  • Registration Number

    110452

  • Incorporation Date

    28 February 2023

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 4 Days
Company report

Brasil Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Brasil Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Brasil Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Veera Sathesh Gandhi Kamisetty Director 28 Feb 2023 Current
Sravan Kumar Lakhineni Director 28 Feb 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Individual Subscriber - Past
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Brasil Pharmaceuticals.

Enhance accessibility to Brasil Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Brasil Pharmaceuticals revenue growth over time
Brasil Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Brasil Pharmaceuticals?

Unlock access to Brasil Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Brasil Pharmaceuticals?

Unlock and access historical data on people associated with Brasil Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Brasil Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brasil Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Brasil Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Veera Sathesh Gandhi Kamisetty was appointed as a Director was appointed as a Director on 28 Feb 2023 & has been associated with this company since 3 years 4 days . was documented.

  • Director Appointment

    Sravan Kumar Lakhineni was appointed as a Director was appointed as a Director on 28 Feb 2023 & has been associated with this company since 3 years 4 days . was recorded as a recent event.

  • Company Incorporation

    Brasil Pharmaceuticals Private Limited was registered on 28 Feb 2023 with Roc Vijayawada & aged 3 years 4 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Brasil Pharmaceuticals Private Limited?

The CIN of Brasil Pharmaceuticals Private Limited is U21001AP2023PTC110452.

Where is Brasil Pharmaceuticals Private Limited headquartered?

Brasil Pharmaceuticals Private Limited is headquartered at 49-35-49, 3Rd Floor, Sri Nivasam, Visakhapatnam, Andhra Pradesh, 530016.

When was Brasil Pharmaceuticals Private Limited incorporated?

Brasil Pharmaceuticals Private Limited was incorporated on 28 February 2023.

Who are the current directors of Brasil Pharmaceuticals Private Limited?

The current directors of Brasil Pharmaceuticals Private Limited are

What is the primary industry of Brasil Pharmaceuticals Private Limited?

The primary industry of Brasil Pharmaceuticals Private Limited is Paper.

Is Brasil Pharmaceuticals Private Limited a listed company?

Brasil Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Brasil Pharmaceuticals Private Limited?

The authorized capital of Brasil Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available